Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

Bibliographic Details
Main Authors:	Rosén, Christoffer, Andersson, Carl-Henrik, Andreasson, Ulf, Molinuevo, José L., Bjerke, Maria, Rami, Lorena, Lladó, Albert, Blennow, Kaj, Zetterberg, Henrik
Format:	Online
Language:	English
Published:	S. Karger AG 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164083/

Similar Items

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
by: Janelidze, Shorena, et al.
Published: (2015)

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
by: Hellwig, Konstantin, et al.
Published: (2015)

Serum YKL-40 Levels and Chitotriosidase Activity in Patients with Beta-Thalassemia Major
by: Musumeci, Maria, et al.
Published: (2014)

Fluid biomarkers in Alzheimer’s disease – current concepts
by: Rosén, Christoffer, et al.
Published: (2013)

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
by: Öhrfelt, Annika, et al.
Published: (2016)

Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
by: Hölttä, Mikko, et al.
Published: (2013)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
by: Andreasson, Ulf, et al.
Published: (2016)

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
by: Bremell, Daniel, et al.
Published: (2013)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
by: Skillbäck, Tobias, et al.
Published: (2013)

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
by: Stomrud, Erik, et al.
Published: (2015)

Plasma tau levels in Alzheimer's disease
by: Zetterberg, Henrik, et al.
Published: (2013)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
by: Blennow, Kaj, et al.
Published: (2015)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
by: Mattsson, Niklas, et al.
Published: (2016)

No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
by: Cicognola, Claudia, et al.
Published: (2016)

Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
by: Johansson, Per, et al.
Published: (2013)

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
by: Per Johansson, et al.

Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke
by: Hjalmarsson, Clara, et al.
Published: (2014)

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
by: Sarah Westwood, et al.
Published: (2017-04-01)

APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
by: Sjödin, Simon, et al.
Published: (2015)

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
by: Wennström, Malin, et al.
Published: (2015)

Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
by: Lewczuk, Piotr, et al.
Published: (2016)

Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS
by: Hölttä, Mikko, et al.
Published: (2012)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
by: Hall, Sara, et al.
Published: (2016)

YKL-40 levels are independently associated with albuminuria in type 2 diabetes
by: Røndbjerg, Anne K, et al.
Published: (2011)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
by: Mulugeta, Ezra, et al.
Published: (2011)

Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study
by: Bromander, Sara, et al.
Published: (2012)

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
by: Martínez, M Alba Mañé, et al.
Published: (2015)

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
by: Heslegrave, Amanda, et al.
Published: (2016)

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
by: Rosengren Lars, et al.
Published: (2010-07-01)

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke
by: Ann De Vos, et al.
Published: (2017-08-01)

YKL-40 correlates with the phenotype of asthma
by: Specjalski, Krzysztof, et al.
Published: (2015)

Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele
by: Padayachee, E.R., et al.
Published: (2016)

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
by: Kvartsberg, Hlin, et al.
Published: (2015)

Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls
by: Rolstad, Sindre, et al.
Published: (2015)

Biomarkers for Microglial Activation in Alzheimer's Disease
by: Lautner, Ronald, et al.
Published: (2011)

The relationship between cerebrospinal fluid tau markers, hippocampal volume, and delayed primacy performance in cognitively intact elderly individuals
by: Bruno, Davide, et al.
Published: (2015)

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
by: Sjödin, Simon, et al.
Published: (2016)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
by: Hansson, Oskar, et al.
Published: (2014)

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
by: Bruno Becker, et al.
Published: (2018-08-01)

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
by: Brinkmalm, Ann, et al.
Published: (2014)